Moderna ( (MRNA) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Moderna’s stock has seen a decline following reports that link COVID-19 vaccines to child deaths, causing investor concern. Despite this, analysts maintain that there is still considerable upside potential for the company. The market remains uncertain as the implications of these reports on future vaccine policies are yet to be determined.
More about Moderna
YTD Price Performance: -39.55%
Average Trading Volume: 9,443,022
Technical Sentiment Signal: Sell
Current Market Cap: $9.88B
For further insights into MRNA stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.